Back
Apellis Pharmaceuticals Stock Predictions
![](/images/offers/ims/large/offer1.jpg)
Potential crash warning signs flashing again on my charts
Here's my #1 indicator to try out now.
Sell
37
APLS
Apellis Pharmaceuticals
Last Price:
41.02
Seasonality Move:
5.93%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer20.jpg)
#1 free indicator forecasts the next market drop here
Discover my #1 trading indicator here.Apellis Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 19.6% based on the past 6 years of stock performance.
- Apellis Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Apellis Pharmaceuticals Stock Undervalued?
The current Apellis Pharmaceuticals [APLS] share price is $41.05. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. - APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 19.6% based on the past 6 years of stock performance.
Apellis Pharmaceuticals Stock Rating
Sell
37
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals overpriced?
- Apellis Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Apellis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
73.80
52-Week Low:
33.49
Prediction Charts
Market Cap:
5B
Price in USD:
41.05
Volume:
1.79M
Beta:
0.85
Technical Analysis
SMA50:
37.98
SMA100:
40.63
SMA200:
50.76
52-Wk Change:
-3.98%
Stock Predictions
-
Is Apellis Pharmaceuticals stock public?
Yes, Apellis Pharmaceuticals is a publicly traded company. -
What is the Apellis Pharmaceuticals stock quote today?
The Apellis Pharmaceuticals stock price is 41.05 USD today. -
How to buy Apellis Pharmaceuticals stock online?
You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-19 | 37.12 | 38.57 | 38.57 | 36.82 |
Aug-20 | 38.00 | 38.95 | 39.04 | 37.76 |
Aug-21 | 38.57 | 39.86 | 40.55 | 38.57 |
Aug-22 | 40.42 | 39.14 | 40.66 | 38.87 |
Aug-23 | 39.42 | 40.11 | 40.68 | 39.42 |
Aug-26 | 40.11 | 39.84 | 40.73 | 39.72 |
Aug-27 | 39.48 | 39.60 | 39.68 | 38.37 |
Aug-28 | 39.60 | 38.18 | 40.15 | 38.06 |
Aug-29 | 38.41 | 38.72 | 39.21 | 38.12 |
Aug-30 | 38.72 | 38.87 | 39.29 | 38.43 |
Sep-3 | 38.36 | 38.79 | 40.35 | 38.18 |
Sep-4 | 38.60 | 37.78 | 39.14 | 37.52 |
Sep-5 | 37.77 | 39.29 | 39.34 | 37.45 |
Sep-6 | 39.67 | 41.05 | 41.64 | 39.38 |
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals Forecast Revenue Growth
Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.